Nightingale Health Oyj OMXHEX:HEALTH:
ISSUED ON MONDAY PROFIT WARNING
WILL NOT REACH ITS PREVIOUSLY COMMUNICATED MILESTONE OF MORE THAN 50% REVENUE GROWTH Y/Y FOR THE CURRENT FINANCIAL YEAR
REASON IS A SHIFT IN THE TIMELINE OF A MAJOR PROJECT ANNOUNCED ON SEPTEMBER 16, 2025, WITH CONTRACT VALUE OF EUR 2.4 MILLION
TIMELINE SHIFT MOVES ABOUT EUR 2 MILLION OF REVENUE INTO THE NEXT FINANCIAL YEAR
STILL EXPECTS CURRENT-YEAR REVENUE TO GROW BY ABOUT 20% (+/- 5%) Y/Y
EXPECTS REVENUE TO EXCEED EUR 10 MILLION IN THE NEXT FINANCIAL YEAR
TO ANNOUNCE MORE DETAILED TARGETS FOR 2026–2027 AS PART OF FULL-YEAR RESULT RELEASE IN SEPTEMBER 2026
Source text for Workspace:
Further company coverage:

